Optimi Health Corp. (OPTH)
NASDAQ: OPTH · Real-Time Price · USD
4.090
+0.030 (0.74%)
At close: Jun 26, 2026, 4:00 PM EDT
4.020
-0.070 (-1.71%)
After-hours: Jun 26, 2026, 4:55 PM EDT

Company Description

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.

The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets.

The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements.

It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.

Optimi Health Corp.
Country Canada
Founded 2020
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 8
CEO Dane Stevens

Contact Details

Address:
269 David Brown Way
Princeton, BC V0X 1W0
Canada
Phone 778-761-4551
Website optimihealth.ca

Stock Details

Ticker Symbol OPTH
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency CAD
CIK Code 0002027329
CUSIP Number 68405H308
ISIN Number CA68405H3080

Key Executives

Name Position
Dane Stevens Co-Founder, Chief Executive Officer, Chief Marketing Officer and Director
John James Wilson Co-Founder and Chairman
Bryan Edward Safarik Co-Founder, Chief Operating Officer and Director
Jacob Safarik Interim Chief Financial Officer and Director
Dr. Preston A. Chase Chief Science Officer
Ann Little Human Resources Manager
Leah Hodges Corporate Secretary